January 06, 2005
1 min read
Save

Diabetes may be a risk factor for glaucomatous optic neuropathy

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Prospective studies are warranted to determine if open-angle glaucoma patients with diabetes have a more aggressive course than patients with glaucoma but without diabetes, a group of Japanese researchers said.

Makoto Nakamura, MD, PhD, and colleagues at the Kobe University Graduate School of Medicine noted that retinal ganglion cell apoptosis is a fundamental pathology of open-angle glaucoma. Controversy remains about whether diabetes and open-angle glaucoma are associated, they said. “This inconsistency is derived from selection-, recall- or survival-bias or misclassification due to low incidence of the two diseases,” the researchers said.

The latest data from this group showed that retinas from rats with streptozotocin-induced diabetes had significantly more apoptotic cells than those from rats with diabetes alone or with chronic glaucoma alone.

The study is published in the January issue of Ophthalmologica.